Hanall acquires local patent for combination bill

Published: 2010-06-08 06:56:00

Updated: 2010-06-08 06:56:00

Hanall Biopharma said on June 4 that it won a Korean patent for a combination product containing thiazide and angiotensin receptor block for treatment of hypertension.

Hanall said its studies have shown that patients taking this pill are more compliant than those taking separate pills to treat...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK